- Home
- RUN vs SLNO Comparison
RUN vs SLNO Comparison
Compare RUN & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUN
- SLNO
- Stock Information
- Founded
- RUN 2007
- SLNO 1999
- Country
- RUN United States
- SLNO United States
- Employees
- RUN N/A
- SLNO N/A
- Industry
- RUN Industrial Machinery/Components
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RUN Miscellaneous
- SLNO Health Care
- Exchange
- RUN Nasdaq
- SLNO Nasdaq
- Market Cap
- RUN 3.7B
- SLNO 3.7B
- IPO Year
- RUN 2015
- SLNO 2014
- Fundamental
- Price
- RUN $17.17
- SLNO $46.98
- Analyst Decision
- RUN Buy
- SLNO Strong Buy
- Analyst Count
- RUN 20
- SLNO 9
- Target Price
- RUN $20.18
- SLNO $114.89
- AVG Volume (30 Days)
- RUN 7.8M
- SLNO 2.2M
- Earning Date
- RUN 11-06-2025
- SLNO 11-04-2025
- Dividend Yield
- RUN N/A
- SLNO N/A
- EPS Growth
- RUN N/A
- SLNO N/A
- EPS
- RUN N/A
- SLNO N/A
- Revenue
- RUN $2,316,656,000.00
- SLNO $98,675,000.00
- Revenue This Year
- RUN $11.35
- SLNO N/A
- Revenue Next Year
- RUN $9.26
- SLNO $181.30
- P/E Ratio
- RUN N/A
- SLNO N/A
- Revenue Growth
- RUN 13.79
- SLNO N/A
- 52 Week Low
- RUN $5.38
- SLNO $41.50
- 52 Week High
- RUN $22.44
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- RUN 38.89
- SLNO 31.94
- Support Level
- RUN $18.72
- SLNO $66.12
- Resistance Level
- RUN $21.34
- SLNO $69.99
- Average True Range (ATR)
- RUN 1.28
- SLNO 3.71
- MACD
- RUN -0.36
- SLNO -2.47
- Stochastic Oscillator
- RUN 10.37
- SLNO 18.57
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.